当前位置: X-MOL 学术Cancer Discov. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Heterologous Cancer Vaccines plus Checkpoint Inhibitors Show Therapeutic Benefit.
Cancer Discovery ( IF 29.7 ) Pub Date : 2022-11-02 , DOI: 10.1158/2159-8290.cd-rw2022-158


Dual heterologous vaccine regimen and checkpoint inhibitor treatment promotes potent and long-lasting T-cell responses.

中文翻译:

异源癌症疫苗加检查点抑制剂显示治疗益处。

双异源疫苗方案和检查点抑制剂治疗可促进有效和持久的 T 细胞反应。
更新日期:2022-09-02
down
wechat
bug